Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Mechanism of action of new antiarthritic drug KE-298

July 9, 1998

MX-68: mechanisms underlying antiinflammatory activity

July 9, 1998

Bone-sparing antiinflammatory benzamide under investigation at Daiichi

July 9, 1998

Vertex/Kissei select development candidate from p38 MAP kinase inhibitor program

July 8, 1998

Long-term safety and efficacy data presented for Enbrel

July 8, 1998

Series of MMP and TACE inhibitors patented by American Cyanamid

July 7, 1998

Boston Life Sciences submits further data supporting Therafectin NDA

July 3, 1998

Additional phase III results reported for Cypress Bioscience's Prosorba Column

July 1, 1998

Celltech scientists discover potent and selective inhibitors of protein kinases

June 26, 1998

HMR discloses preparation and use of series with MMP-inhibitory activity

June 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...